# Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans

> **NCT02727868** · NA · COMPLETED · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 30 (actual)

## Conditions studied

- Patient With Breast Cancer

## Interventions

- **GENETIC:** blood samples

## Key facts

- **NCT ID:** NCT02727868
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-03
- **Primary completion:** 2017-06-02
- **Final completion:** 2017-06-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02727868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02727868, "Assessment of the Mutation of Pig-A Gene as Biomarker of Genotoxic Exposure in Humans". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02727868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*